Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
This is a gigantic market right now
TB-500 may support the synovial and subchondral environments surrounding cartilage, improving the overall joint milieu even if direct cartilage effects remain limited
If a protocol specifies doses in units without defining the conversion factor, contact the protocol author for clarification before proceeding
It is well-tolerated in animal and early clinical studies, even at multi-milligram doses [12]
Limited human self-experiments note mild injection-site discomfort, brief headaches, and occasional nausea
Manufactured by Eli Lilly, the medication has successfully passed phase I and II clinical trials and is currently in phase III trials
US$ 27.72
US$ 22.19
US$ 28.78
US$ 25.81
US$ 20.91
US$ 23.42
US$ 23.09
